What is the recommended dosage of Co-amoxiclav (amoxicillin/clavulanic acid) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Co-Amoxiclav Pediatric Dosing

For most pediatric infections, use high-dose amoxicillin-clavulanate at 90 mg/kg/day of the amoxicillin component with 6.4 mg/kg/day of clavulanate, divided into 2 doses (BID), which provides the optimal 14:1 ratio formulation. 1

Standard Dosing by Age and Weight

Age-Based Dosing (Using Standard Strength Suspensions)

For children without risk factors for resistant organisms:

  • <1 year (1-12 months): 2.5 ml of 125/31 suspension three times daily 1
  • 1-6 years: 5 ml of 125/31 suspension three times daily 1, 2
  • 7-12 years: 5 ml of 250/62 suspension three times daily 1
  • 12-18 years: 1 tablet (250/125) three times daily 1
  • ≥40 kg: Dose as adults with 500/125 mg tablet every 12 hours 3

High-Dose Regimen (Preferred for Most Infections)

Use 90 mg/kg/day of amoxicillin component divided BID when:

  • Age <2 years 1
  • Daycare attendance 1
  • Recent antibiotic use (within past 30 days) 1
  • Incomplete Haemophilus influenzae type b vaccination (<3 injections) 1
  • Geographic area with high pneumococcal resistance (>10% penicillin-resistant S. pneumoniae) 1
  • Moderate to severe illness 1
  • Concurrent purulent acute otitis media 1
  • Treatment failure with standard-dose amoxicillin 4

This high-dose regimen uses the 400/57 mg per 5 mL or 200/28.5 mg per 5 mL suspension formulations to achieve the 14:1 ratio. 1, 3

Indication-Specific Dosing

Acute Otitis Media

  • Standard dose: 45 mg/kg/day divided BID (using 200/28.5 or 400/57 formulation) 3
  • High-dose: 90 mg/kg/day divided BID for risk factors listed above 4, 1
  • Duration: 10 days 4, 3

Acute Bacterial Rhinosinusitis

  • High-dose amoxicillin-clavulanate (90 mg/kg/day BID) is strongly recommended as first-line therapy in children 4
  • Duration: 10-14 days 4

Community-Acquired Pneumonia

  • <5 years with presumed bacterial pneumonia: 90 mg/kg/day in 2 doses 1
  • <3 years without risk factors: Consider amoxicillin alone at 80-100 mg/kg/day in 3 divided doses first; add clavulanate if incomplete H. influenzae vaccination or concurrent purulent otitis media 1
  • Duration: 10 days 1

Neonates and Infants <12 Weeks

  • 30 mg/kg/day divided every 12 hours (based on amoxicillin component) 3
  • Use 125/31.25 mg per 5 mL formulation (200/28.5 formulation has limited experience in this age group) 3

Critical Dosing Considerations

Why High-Dose Matters

  • High-dose amoxicillin (80-90 mg/kg/day) exceeds the minimum inhibitory concentration for intermediately resistant S. pneumoniae and many highly resistant serotypes 1
  • Using standard doses when high-dose therapy is indicated leads to treatment failure with resistant organisms 1
  • Subtherapeutic doses fail to achieve adequate serum and tissue concentrations and promote antimicrobial resistance 1

Formulation Selection

  • The 14:1 ratio formulation (90/6.4 mg/kg/day) causes less diarrhea than other amoxicillin-clavulanate preparations while maintaining efficacy 1
  • BID dosing is associated with significantly less diarrhea than TID dosing 3
  • Verify suspension concentration (125/31 vs 250/62 vs 200/28.5 vs 400/57) before calculating volume to avoid dosing errors 1

Maximum Doses

  • Maximum single dose: 2 grams per dose regardless of weight 1
  • Maximum daily dose: 4000 mg/day for children ≥5 years 1

Administration and Monitoring

Administration

  • Take at the start of meals to enhance clavulanate absorption and minimize gastrointestinal intolerance 3
  • Shake suspension well before each use 3
  • Reconstituted suspension must be refrigerated and discarded after 10 days 3

Expected Clinical Response

  • Clinical improvement should be evident within 48-72 hours 1, 2
  • If no improvement or worsening after 72 hours, reassess diagnosis, consider atypical pathogens, evaluate for complications, or switch antibiotics 1

Common Pitfalls to Avoid

  1. Do NOT use 250/125 tablets in children <40 kg - these contain 125 mg clavulanate (not 62.5 mg) and are not interchangeable with 250/62.5 chewable tablets 3

  2. Do NOT underdose - an 80 mg total daily dose for a 5-year-old is grossly inadequate and promotes resistance 1

  3. Do NOT prescribe antibiotics for viral URTIs - the vast majority of URTIs are viral and do not benefit from antibiotics 1

  4. Ensure the child meets criteria for bacterial infection before prescribing: persistent symptoms >10 days without improvement, severe symptoms (fever ≥39°C with purulent nasal discharge for ≥3 consecutive days), or "double sickening" (worsening after initial improvement) 1

Adverse Effects

  • Most common: Diarrhea, nausea, vomiting (gastrointestinal effects more common with higher clavulanate doses) 1, 3
  • Less common: Rash, urticaria, hypersensitivity reactions 1, 2
  • Monitor for allergic reactions, especially with first few doses 2

References

Guideline

Amoxicillin-Clavulanate Dosing in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Amoxicillin-Clavulanate Dosing Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.